Cargando…

Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature

Hepatic carcinoma expressing inhibin is a recently described neoplasm with varied architecture, including trabecular, pseudoglandular, follicular/microcystic, organoid, solid and tubular patterns of growth. We report a case of hepatic carcinoma expressing inhibin that occurred in a 47-year-old woman...

Descripción completa

Detalles Bibliográficos
Autores principales: Syrnioti, Antonia, Athanasiou, Evangelia, Hytiroglou, Prodromos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists/The Korean Society for Cytopathology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288896/
https://www.ncbi.nlm.nih.gov/pubmed/35698738
http://dx.doi.org/10.4132/jptm.2022.04.07
_version_ 1784748550070992896
author Syrnioti, Antonia
Athanasiou, Evangelia
Hytiroglou, Prodromos
author_facet Syrnioti, Antonia
Athanasiou, Evangelia
Hytiroglou, Prodromos
author_sort Syrnioti, Antonia
collection PubMed
description Hepatic carcinoma expressing inhibin is a recently described neoplasm with varied architecture, including trabecular, pseudoglandular, follicular/microcystic, organoid, solid and tubular patterns of growth. We report a case of hepatic carcinoma expressing inhibin that occurred in a 47-year-old woman presenting with epigastric and back pain. The tumor was located in the left hepatic lobe and measured 12 cm in diameter. On immunohistochemical stains, the neoplastic cells were positive for inhibin, as well as cytokeratins 7, 8/18 and 19. There was mild focal expression of synaptophysin, and lack of expression of hepatocytic markers. The histogenesis of hepatic carcinoma expressing inhibin is presently uncertain. From a practical point of view, this neoplasm can potentially cause diagnostic pitfalls by simulating other primary or metastatic tumors, such as hepatocellular carcinoma, cholangiocarcinoma, neuroendocrine tumors, and follicular carcinoma of thyroid gland. Performing inhibin immunostain could assist in the differential diagnosis of liver tumors with unusual histologic features.
format Online
Article
Text
id pubmed-9288896
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Korean Society of Pathologists/The Korean Society for Cytopathology
record_format MEDLINE/PubMed
spelling pubmed-92888962022-07-29 Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature Syrnioti, Antonia Athanasiou, Evangelia Hytiroglou, Prodromos J Pathol Transl Med Case Study Hepatic carcinoma expressing inhibin is a recently described neoplasm with varied architecture, including trabecular, pseudoglandular, follicular/microcystic, organoid, solid and tubular patterns of growth. We report a case of hepatic carcinoma expressing inhibin that occurred in a 47-year-old woman presenting with epigastric and back pain. The tumor was located in the left hepatic lobe and measured 12 cm in diameter. On immunohistochemical stains, the neoplastic cells were positive for inhibin, as well as cytokeratins 7, 8/18 and 19. There was mild focal expression of synaptophysin, and lack of expression of hepatocytic markers. The histogenesis of hepatic carcinoma expressing inhibin is presently uncertain. From a practical point of view, this neoplasm can potentially cause diagnostic pitfalls by simulating other primary or metastatic tumors, such as hepatocellular carcinoma, cholangiocarcinoma, neuroendocrine tumors, and follicular carcinoma of thyroid gland. Performing inhibin immunostain could assist in the differential diagnosis of liver tumors with unusual histologic features. The Korean Society of Pathologists/The Korean Society for Cytopathology 2022-07 2022-06-15 /pmc/articles/PMC9288896/ /pubmed/35698738 http://dx.doi.org/10.4132/jptm.2022.04.07 Text en © 2022 The Korean Society of Pathologists/The Korean Society for Cytopathology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Study
Syrnioti, Antonia
Athanasiou, Evangelia
Hytiroglou, Prodromos
Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature
title Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature
title_full Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature
title_fullStr Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature
title_full_unstemmed Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature
title_short Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature
title_sort hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288896/
https://www.ncbi.nlm.nih.gov/pubmed/35698738
http://dx.doi.org/10.4132/jptm.2022.04.07
work_keys_str_mv AT syrniotiantonia hepaticcarcinomaexpressinginhibincasereportofaproposednovelentityandreviewoftheliterature
AT athanasiouevangelia hepaticcarcinomaexpressinginhibincasereportofaproposednovelentityandreviewoftheliterature
AT hytiroglouprodromos hepaticcarcinomaexpressinginhibincasereportofaproposednovelentityandreviewoftheliterature